drugset / Trial / NCT07057622
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
RandomizedParallel-groupOpen-labelOther
Summary
The study is to evaluate the sstr antagonists, 68Ga-DOTATATE and 177Lu-DOTATATE,as a pair of diagnostic/therapeuticradiopharmaceuticals(theranostics)in patients with NETS
Timeline
- Start
- 2023-12-12
- Primary completion
- 2026-11-24
- Completion
- 2027-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DOTATATE | Peptide | 7400 mbq | — |
| Comparator | Octreotide | Peptide | 60 mg | — |
Indications
No indication recorded.